Navigation Links
Leading researchers honored for progress in cancer prevention, detection and treatment
Date:3/11/2008

which has led to important contributions to the field of cancer research. Tannenbaums study of chemistry as related to cancer has advanced our knowledge of chemical carcinogenesis, the molecular epidemiology of cancer, and more recently, anti-cancer drug development and evaluation. His award lecture will be presented on Sunday, April 13th at 5:30 p.m. in Room 20A-C of the convention center.

Ellen V. Sigal, Ph.D., chairperson of Friends of Cancer Research has been named the 2nd recipient of the AACR Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research. The award, established last year to honor Margaret Foti, Ph.D., M.D. (h.c.) for her exemplary leadership of AACR as chief executive officer, recognizes a true champion of cancer research who embodies the sustained commitment of Margaret Foti to the prevention and cure of cancer. The Award is given to an individual whose leadership and extraordinary achievements in cancer research have made a major impact in the field. Such achievements may include contributions to the acceleration of progress in cancer research; raising national or international awareness of cancer research; or in other ways demonstrating a sustained commitment to cancer research. Sigals award lecture will take place on Sunday, April 13th at 8:15 a.m. in Halls G&H of the convention center.

Lawrence A. Loeb, M.D., Ph.D., professor of pathology and biochemistry at the University of Washington in Seattle is the recipient of this years AACR Princess Takamatsu Memorial Lectureship. Loeb is honored for his distinguished career in cancer research, as well as his work in actively promoting collaboration in cancer research between American and Japanese investigators. Supported by the Princess Takamatsu Cancer Research Fund, the lectureship was established in 2007 in honor of the late Princess Takamatsu of Japan and recognizes an individual scientist whose novel and significant work has had or may have
'/>"/>

Contact: Jennifer Ryan
jennifer.ryan@aacr.org
267-646-0558
American Association for Cancer Research
Source:Eurekalert

Page: 1 2 3 4 5 6 7

Related medicine news :

1. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
2. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
3. Leading Child Abuse Center Releases Back to School Tips to Protect Children From Internet Predators
4. Leading-edge body sensor could help produce sporting champions
5. Hospital Quality Info on Web Can Be Misleading
6. AT&T Establishes New Network Services for Leading Medical Liability Insurer
7. Video and Photo: Leading CEOs Launch Alliance With American Red Cross to Strengthen Nations Preparedness for Disasters
8. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
9. Sentillion Positioned in Visionaries Quadrant in Leading Industry Analyst Firms User Provisioning Magic Quadrant
10. Leading Asthma and Allergy Author and Counselor Joins The HealthCentral Network As Expert
11. Long Term Care Insurance Gains Momentum Thanks to State Promotions, a Leading Brokerage Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2008)... HR Consulting firm CPEhr, and Junior Achi...hadow Day for 30 high-students from Downtown Busin...cs such as labor law, interviewing techniques and ...f. (PRWEB) July 24, 2008 -- Los Angeles HR Consul...ofit organization, hosted a Job Shadow Day for 30 ...
(Date:7/24/2008)... As America's baby boomers age, more ...s such as diabetes that necessitate the use of med...celet jewelry gives a generation attractive incent...n. , (PRWEB) July 24, 200...g health conditions can make a statement in more w...
(Date:7/23/2008)... N.Y., July 24 /PRNewswire/ -- MediVoice(R), LLC, ... for e-Health and,e-Prescribing, has formed a stra...ovider of interactive, web-based, patient-centered...on systems to integrate and market its,mobile voic...Care(TM),(VTOC) system., "MediVoice is pleased to...
(Date:7/23/2008)...roblem For 10+ Years Even Though Some Kilns Emit M...ement Kilns in AL, CA, IA,IL, MD, MI, MT, NY, OR,...e-USNewswire/ -- For more than a decade,after Cong...rom cement,kilns across the nation, the U.S. Envir...ction. Now, a new study from Earthjustice and the,...
Breaking Medicine News(10 mins):Health News:CPEhr and Junior Achievement Prepare High-School Students For the Workforce 2Health News:CPEhr and Junior Achievement Prepare High-School Students For the Workforce 3Health News:Aging Baby Boomers Meld Life-saving Data and Style with Lauren's Hope Fashion Medical ID Bracelet 2Health News:Aging Baby Boomers Meld Life-saving Data and Style with Lauren's Hope Fashion Medical ID Bracelet 3Health News:MediVoice(R) Partners With VisionTree(R) to Integrate Its Voice-Activated e-Prescribing Solution Into VisionTree's VTOC(TM) Web-Based Patient Management System 2Health News:MediVoice(R) Partners With VisionTree(R) to Integrate Its Voice-Activated e-Prescribing Solution Into VisionTree's VTOC(TM) Web-Based Patient Management System 3Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 2Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 3Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 4Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 5Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 6Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 7
...that a migraine headache decreases over the years.... painful and do not last much long. These findin...he Society annual meeting in Chicago, by Carl Dahl...dical director and founder of the Gothenburg Migra...
...act that will be presented Monday at SLEEP 2007, a...d toddlers born prematurely occurs earlier than e...an among full-term infants. The study, authored b...f West Virginia University, consisted of the respo...
...gh, who was admitted to a hospital in East Delhi a...y raising speculations of a suicide attempt by hi... In a statement to the Delhi Police, Singh said th...e glass window panes broke when he banged his hand...
...worry about the ticking of their biological clocks...rugs that could delay menopause. The news was br...who told a press conference that researchers had f...uld be soon be developed into a pill or an injecti...
Other Medicine News:Health News:Ages Eases the Pain of Migraine 2Health News:Scientists Have Found Way to Delay Menopause 2
(Date:7/23/2008)...swire-FirstCall/ -- Dendreon Corporation,(Nasdaq: ...ndent Data,Monitoring Committee (IDMC) to review i...vival relating to the Company,s Phase 3 IMPACT (IM... also known as D9902B) clinical trial,of PROVENGE(...tigational,active cellular immunotherapy for the t...
(Date:7/22/2008)...RNewswire/ -- Nonin Medical, a leading innovator,o... 20 years, has entered,the clinical testing phase ...al oxygen saturation. Today,s most common applicat...ng of the regional blood oxygenation,in the brain ...comes from an ongoing clinical study at the,Duke U...
(Date:7/22/2008)...dy Confirms Tyrima Exhibits Excellent Drug-Like ...sults Support Initiation of Phase II Clinical Tria...wswire/ -- CeNeRx BioPharma,Inc., a clinical stag...e,treatments for diseases of the central nervous s...andidate Tyrima(TM) into Phase II trials for the,t...
(Date:7/22/2008)...th chemotherapy and pegylated enzyme produces s...erapy alone - - Pegylated enzyme ...FirstCall/ -- Halozyme Therapeutics,Inc. (Nasdaq:...nd,commercializing products targeting the extracel...positive pre-clinical animal efficacy data,for its...
Breaking Medicine Technology:Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market 2CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 2CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 3CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 4Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 2Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 3Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 4Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 5Aflac and the American Association for Cancer Research Unite to Issue Inaugural Aflac Career Development Award for Childhood Cancer Research 4933 1Aflac and the American Association for Cancer Research Unite to Issue Inaugural Aflac Career Development Award for Childhood Cancer Research 4933 2Aflac and the American Association for Cancer Research Unite to Issue Inaugural Aflac Career Development Award for Childhood Cancer Research 4933 3Knowledge Based Reconstruction Demonstrates Accuracy in Obtaining Ventricular Volume and Function in Tetralogy of Fallot Patients According to Ventri 1921 1Knowledge Based Reconstruction Demonstrates Accuracy in Obtaining Ventricular Volume and Function in Tetralogy of Fallot Patients According to Ventri 1921 2Alexza Announces Positive Phase 1 Results With AZ 007 28Staccato 28R 29 Zaleplon 29 1919 1Alexza Announces Positive Phase 1 Results With AZ 007 28Staccato 28R 29 Zaleplon 29 1919 2Alexza Announces Positive Phase 1 Results With AZ 007 28Staccato 28R 29 Zaleplon 29 1919 3Alexza Announces Positive Phase 1 Results With AZ 007 28Staccato 28R 29 Zaleplon 29 1919 4Measurements Poor for Assessing Clinical Trials With Children 17915 1Measurements Poor for Assessing Clinical Trials With Children 17915 2
....H.--(BUSINESS WIRE)--May 24, 2007 - Bentley,Pharm...utical,company, today announced that a late breaki...pted for a poster presentation at the,American Dia...ago.,The abstract, entitled "Results of a Randomiz...y of Intranasal Insulin Spray,(Nasulin(TM)) and In...
...O, May 23, 2007 /PRNewswire-FirstCall/ -- Shire pl...of the,investigational medication guanfacine exten...), a selective,alpha-2A-adrenoceptor agonist. Thes...olled studies and two long-term phase III,open-lab...tric,Association (APA) annual meeting, demonstrate...
Other Medicine Technology:Bentley Late Breaking Abstract Accepted for Poster Presentation at,American Diabetes Association Scientific Sessions 2Bentley Late Breaking Abstract Accepted for Poster Presentation at,American Diabetes Association Scientific Sessions 3Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 2Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 3Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 4Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 5Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 6Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 7Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 8
...nts incorporate a layered design unique in the ind...to prevent stray electrosurgical burns along the s...e or capacitive coupling; a well-documented patien...l AEM Instruments provides a neutral return path f...
...nts incorporate a layered design unique in the ind...to prevent stray electrosurgical burns along the s...e or capacitive coupling; a well-documented patien...l AEM Instruments provides a neutral return path f...
...nts incorporate a layered design unique in the ind...to prevent stray electrosurgical burns along the s...e or capacitive coupling; a well-documented patien...l AEM Instruments provides a neutral return path f...
...nts incorporate a layered design unique in the ind...to prevent stray electrosurgical burns along the s...e or capacitive coupling; a well-documented patien...l AEM Instruments provides a neutral return path f...
Medicine Products: